Focused multivector ultraviolet (FMUV) technology rapidly eradicates SARS-CoV-2 in-vitro: Implications for hospital disinfection of COVID-19 environments - 18/06/22
, Thomas J. Walsh, MD, PhD b
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Highlights |
• | Focused Multivector Ultraviolet technology rapidly killed the SARS-CoV-2 in-vitro. |
• | Mean reductions of 99.9999% SARS-CoV-2 were achieved within 90 seconds. |
• | Focused Multivector Ultraviolet technology is effective for SARS-CoV-2 disinfection. |
Abstract |
Focused Multivector Ultraviolet technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 106 plaque forming units of USA-WA1 Washington index patient strain of SARS-CoV-2 and exposed to ultraviolet, resulting in mean reductions of 99.99% within 30 seconds, 99.999% within 60 seconds, and 99.9999% within 90 seconds. These results support the effectiveness of Focused Multivector Ultraviolet technology for SARS-CoV-2 disinfection.
El texto completo de este artículo está disponible en PDF.Key words : UV disinfection, Shadowless delivery
Esquema
| Funding/support: T.J.W. and V.P. served as advisors to PurpleSun; fees from their consultancy were paid to Weill Cornell Medicine. |
|
| Conflicts of interest: None to report. |
Vol 50 - N° 7
P. 828-830 - juillet 2022 Regresar al número
Artículo precedente
- Prevalence and incidence of tuberculosis in health workers: A systematic review of the literature
- Eni Hilário da Silva, Ercilia Lima, Talita Raquel dos Santos, Maria Clara Padoveze
- Impact of COVID-19 on hospital acquired infections
- Thomas Halverson, Anessa Mikolajczak, Nallely Mora, Christina Silkaitis, Savanna Stout
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.